companydata.dkcompanydata.dk

TAK Biopharma IVS: Financial statements 2019

CVR: 37962872

Source: annual report 2019, Danish Business Authority

01/01/2019 – 31/12/2019

TAK Biopharma IVS (CVR 37962872) has filed annual accounts for 2019. In 2019, the company reported revenue of DKK 379,951 and a net result of DKK -22,190 compared with DKK 149,224 the year before. That is an increase of 84.9% compared with the year before. The profit margin was -5.8%. Equity in the 2019 report amounted to DKK -59,720.

Revenue
DKK 379,951
Gross Profit
DKK 299,990
Profit/Loss
DKK -22,190
Equity
DKK -59,720
Total Assets
DKK 70,309

Development

YearRevenueGross ProfitProfit/LossEquityEmployees
2019380K300K-22K-60K-
2018206K149K149K-38K-
201780K67K-23K-187K-

Official annual report

View the official annual report directly on the page with a Pro subscription.

Screen every Danish company

Combine filters on financials, industry, geography, property and risk, and instantly see which companies match.

Try company screening

Events in 2019

TAK Biopharma IVS: The 2018 annual report is outJun 4, 2019

TAK Biopharma IVS has published its annual report for 2018. Revenue came to DKK 205,532, and the net result was DKK 149,224.

About TAK Biopharma IVS

TAK Biopharma IVS was a Danish company of the type Iværksætterselskab based in København N, founded in 2016. The company has been dissolved on 20 June 2021. The company was registered under the industry Fremstilling af farmaceutiske råvarer. The company has 1 employee (2020). In 2019, the company reported revenue of DKK 379,951 and a net result of DKK -22,190 compared with DKK 149,224 the year before. Equity in the 2019 report amounted to DKK -59,720.

Source: annual report 2019, Danish Business Authority

Other financial years